Status:

COMPLETED

Front-End Processing 3.0

Lead Sponsor:

MED-EL Elektromedizinische Geräte GesmbH

Conditions:

Hearing Loss

Hearing Loss, Sensorineural

Eligibility:

All Genders

18+ years

Brief Summary

This study investigated the impact of Automatic Sound Management 3.0 (i.e. ambient noise reduction, transient noise reduction and an adaptive intelligence) as implemented in the SONNET2 on CI users' s...

Detailed Description

MED-EL Cochlear Implants (CI) provide auditory sensations via electrical stimulation of the auditory pathways for severely to profoundly hearing-impaired individuals who obtain little or no benefit fr...

Eligibility Criteria

Inclusion

  • A minimum of 18 years old
  • Experienced user (≥ 6 months) of a MED-EL cochlear implant (CI; C40+ and later model)
  • Experienced user of a MED-EL SONNET audio processor (≥ 6 months)
  • Post-lingual onset of bilateral severe to profound sensory-neural hearing loss
  • Unilateral CI user
  • A minimum of 10 active electrodes
  • A minimum of 40% speech recognition in the Freiburg Monosyllables test in quiet at 65 dB sound pressure level (SPL; at the last time tested)
  • Fluent in German (the language of the test centre)
  • Signed and dated Informed Consent Form before the start of any study-specific procedure.

Exclusion

  • Lack of compliance with any inclusion criteria
  • CI user with contralateral hearing equal to or better than 60 dB (PTA measured at 500, 1000, and 2000Hz)
  • User with electric-acoustic stimulation (EAS; user of an EAS audio processor)
  • Implanted with C40X and C40C
  • Implanted with an Auditory Brainstem Implant or Split electrode array
  • Known allergic reactions to components of the investigational medical device
  • Unstable psychological status
  • Anything that, in the opinion of the Investigator, would place the subject at increased risk or preclude the subject's full compliance with or completion of the study

Key Trial Info

Start Date :

April 1 2019

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

March 5 2020

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT03861442

Start Date

April 1 2019

End Date

March 5 2020

Last Update

June 5 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Klinik und Poliklinik für Hals-, Nasen- und Ohrenkrankheiten, plastische und ästhetische Operationen

Würzburg, Bavaria, Germany, 97080